Related Experiment Video
Updated: Jan 28, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
BIM deletion polymorphism predicts poor response to EGFR-TKIs in nonsmall cell lung cancer: An updated meta-analysis
Wenxia Su1, Xiaoyun Zhang1, Xin Cai1
1Department of Physiology.
Background:
A germline deletion in BIM (B cell lymphoma-2-like 11) gene has been shown to impair the apoptotic response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in vitro but its impact on response to EGFR-TKIs in patients of nonsmall cell lung cancer (NSCLC) remains controversial.
Methods:
Eligible literature were searched and screened. Objective response rate (ORR) and disease control rate (DCR) were extracted and aggregated with odds ratio (OR). Hazard ratio (HR) and 95% confidence interval (CI) for progression-free survival (PFS) and overall survival (OS) were extracted and aggregated based on random-effect model.
Results:
Fourteen studies including 2694 NSCLC patients were eligible. Individuals harboring BIM deletion polymorphism had inferior ORR (OR = 0.49, 95% CI: 0.34-0.70, P < .001), inferior DCR (OR = 0.50, 95% CI: 0.30-0.84, P = .009). Patients with BIM deletion had shorter OS despite of the heterogeneity between countries (in subgroup of South Korea and Taiwan, HR = 1.34, 95% CI: 1.18-1.53, P < .001; in subgroup of other countries, HR = 2.43, 95% CI: 2.03-2.91, P < .001). The pooled analysis of PFS showed great heterogeneity (I = 79%). All the reported characteristics did not account for the heterogeneity. However, 2 subgroups could be obtained through sensitivity analysis. In one subgroup, patients with BIM deletion polymorphism had shorter PFS (HR = 2.03, 95% CI: 1.71-2.40, P < .001), while in the other subgroup, no significant difference was observed (HR = 0.92, 95% CI: 0.79-1.06, P = .25).
Conclusion:
NSCLC patients with BIM deletion polymorphism show poor ORR, DCR, and OS after EGFR-TKIs treatment. BIM deletion polymorphism indicates poor response to EGFR-TKIs, and it could be used as a predictor to identify those who would benefit from EGFR-TKIs in NSCLC patients.
Insights
Non-small cell lung cancer (NSCLC) patients with BIM deletion polymorphism show a poorer response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). This genetic marker indicates a reduced likelihood of treatment success and can help identify patients who may not benefit from EGFR-TKIs.
Area of Science:
- Oncology
- Genetics
- Pharmacogenomics
Background:
- Germline deletion in the BIM gene is implicated in reduced apoptotic response to EGFR TKIs in vitro.
- The clinical significance of BIM deletion polymorphism in NSCLC patients treated with EGFR TKIs remains debated.
Purpose of the Study:
- To meta-analyze the impact of BIM deletion polymorphism on the efficacy of EGFR TKIs in NSCLC patients.
- To evaluate BIM deletion polymorphism as a predictive biomarker for EGFR TKI treatment response in NSCLC.
Main Methods:
- Systematic literature search and screening of eligible studies.
- Extraction and aggregation of objective response rate (ORR) and disease control rate (DCR) using odds ratios (OR).
- Meta-analysis of progression-free survival (PFS) and overall survival (OS) using hazard ratios (HR) and random-effect models.
Main Results:
- Fourteen studies with 2694 NSCLC patients were included.
- BIM deletion polymorphism was associated with inferior ORR (OR=0.49) and DCR (OR=0.50).
- Patients with BIM deletion had significantly shorter OS (HR=1.34 to 2.43) and variable PFS outcomes across subgroups.
Conclusions:
- NSCLC patients with BIM deletion polymorphism exhibit poor response (ORR, DCR) and survival (OS) to EGFR TKIs.
- BIM deletion polymorphism serves as a potential predictive biomarker for identifying NSCLC patients unlikely to benefit from EGFR TKIs.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Predicting Molecular Geometry
Directing Effect of Substituents: meta-Directing Groups
Cancer Survival Analysis
Single Nucleotide Polymorphisms-SNPs
Lung Capacity
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.